Abstract
The article addresses criteria for access to pharmacological cognitive enhancement technologies, especially modafinil and methylphenidate, to healthy adults. From the perspective of equalitarian justice and taking as point of reference Rawls’ theory of justice it argues in favor of a policy of open market access, but facilitated for the worst-off.
| Translated title of the contribution | Methylphenidate and modafinil: Egalitarian justice and policies of access to pharmacological cognitive enhancement |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 179-188 |
| Number of pages | 10 |
| Journal | Acta Bioethica |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Methylphenidate and modafinil: Egalitarian justice and policies of access to pharmacological cognitive enhancement'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver